DEERFIELD MANAGEMENT COMPANY, L.P. Quant / Systematic

Location: New York, NY

CIK: 0001009258 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $2.792B (83.3% shares, 16.7% debt)

Holdings (103)

HORIZON PHARMA PLC 4.6%
Value $129M Shares 6,609,894 Est. Cost Unrealized
HOMOLOGY MEDICINES INC 4.3%
Value $119M Shares 5,227,035 Est. Cost Unrealized
HORIZON PHARMA INVT LTD 3.6%
Value $99.54M Shares 99,100,000 Est. Cost Unrealized
NEVRO CORP 3.6%
Value $99.4M Shares 100,000,000 Est. Cost Unrealized
AERIE PHARMACEUTICALS INC 3.4%
Value $94.81M Shares 1,540,448 Est. Cost Unrealized
DEXCOM INC 3.0%
Value $84.16M Shares 55,000,000 Est. Cost Unrealized
MYLAN N V 2.4%
Value $67.42M Shares 1,842,111 Est. Cost Unrealized
PORTOLA PHARMACEUTICALS INC 2.3%
Value $65.39M Shares 2,455,586 Est. Cost Unrealized
DBV TECHNOLOGIES S A 2.3%
Value $65.13M Shares 2,900,000 Est. Cost Unrealized
ANAB ANAPTYSBIO INC 2.3%
Value $64.6M Shares 647,466 Est. Cost Unrealized
ACCELERON PHARMA INC 2.3%
Value $63.96M Shares 1,117,651 Est. Cost Unrealized
ENDOCYTE INC 2.2%
Value $62.41M Shares 3,514,084 Est. Cost Unrealized
INTERSECT ENT INC 2.2%
Value $61.75M Shares 2,147,950 Est. Cost Unrealized
MYOKARDIA INC 2.1%
Value $59.79M Shares 917,000 Est. Cost Unrealized
BCRX BIOCRYST PHARMACEUTICALS 1.9%
Value $52.73M Shares 6,910,789 Est. Cost Unrealized
ACHC ACADIA HEALTHCARE COMPANY IN 1.8%
Value $50.15M Shares 1,424,571 Est. Cost Unrealized
ARGX ARGENX SE 1.8%
Value $49.79M Shares 656,500 Est. Cost Unrealized
KEMPHARM INC 1.7%
Value $48.28M Shares 75,000,000 Est. Cost Unrealized
SRPT SAREPTA THERAPEUTICS INC 1.7%
Value $47.81M Shares 296,000 Est. Cost Unrealized
BKD BROOKDALE SR LIVING INC 1.7%
Value $46.28M Shares 4,707,912 Est. Cost Unrealized
WRIGHT MED GROUP N V 1.6%
Value $45.57M Shares 31,500,000 Est. Cost Unrealized
ACRS ACLARIS THERAPEUTICS INC 1.6%
Value $44.92M Shares 3,093,416 Est. Cost Unrealized
CVS CVS HEALTH CORP 1.6%
Value $44.62M Shares 566,800 Est. Cost Unrealized
XERIS PHARMACEUTICALS INC 1.6%
Value $43.93M Shares 2,498,666 Est. Cost Unrealized
BLUEPRINT MEDICINES CORP 1.5%
Value $40.98M Shares 525,000 Est. Cost Unrealized
MIRATI THERAPEUTICS INC 1.4%
Value $39.61M Shares 840,911 Est. Cost Unrealized
GKOS GLAUKOS CORP 1.3%
Value $36.95M Shares 569,356 Est. Cost Unrealized
EDIT EDITAS MEDICINE INC 1.3%
Value $36.87M Shares 1,158,841 Est. Cost Unrealized
INTERCEPT PHARMACEUTICALS IN 1.3%
Value $36.25M Shares 36,000,000 Est. Cost Unrealized
CNC CENTENE CORP DEL 1.3%
Value $35.47M Shares 245,000 Est. Cost Unrealized
EHTH EHEALTH INC 1.2%
Value $34.68M Shares 1,227,061 Est. Cost Unrealized
UHS UNIVERSAL HLTH SVCS INC 1.2%
Value $33.49M Shares 262,000 Est. Cost Unrealized
IMMUNOMEDICS INC 1.2%
Value $33.12M Shares 1,590,000 Est. Cost Unrealized
K2M GROUP HLDGS INC 1.1%
Value $30.08M Shares 20,000,000 Est. Cost Unrealized
NEVRO CORP 1.1%
Value $29.93M Shares 525,040 Est. Cost Unrealized
GLPG GALAPAGOS NV 1.0%
Value $29.24M Shares 260,064 Est. Cost Unrealized
SEM SELECT MED HLDGS CORP 1.0%
Value $28.08M Shares 1,526,000 Est. Cost Unrealized
KINIKSA PHARMACEUTICALS LTD 1.0%
Value $27.08M Shares 1,061,956 Est. Cost Unrealized
AGIO AGIOS PHARMACEUTICALS INC 1.0%
Value $26.85M Shares 348,200 Est. Cost Unrealized
ELV ANTHEM INC 0.9%
Value $26.04M Shares 95,000 Est. Cost Unrealized
DFB HEALTHCARE ACQUISTION CO 0.9%
Value $25.5M Shares 2,500,000 Est. Cost Unrealized
REATA PHARMACEUTICALS INC 0.9%
Value $24.04M Shares 294,000 Est. Cost Unrealized
VCEL VERICEL CORP 0.8%
Value $22.89M Shares 1,617,730 Est. Cost Unrealized
ASND ASCENDIS PHARMA A S 0.8%
Value $22.68M Shares 320,000 Est. Cost Unrealized
ARVN ARVINAS INC 0.7%
Value $20.81M Shares 1,233,734 Est. Cost Unrealized
RGNX REGENXBIO INC 0.7%
Value $20.76M Shares 275,000 Est. Cost Unrealized
AUDENTES THERAPEUTICS INC 0.7%
Value $19.55M Shares 493,901 Est. Cost Unrealized
SYNLOGIC INC 0.7%
Value $19.4M Shares 1,365,143 Est. Cost Unrealized
FATE FATE THERAPEUTICS INC 0.7%
Value $19.12M Shares 1,173,617 Est. Cost Unrealized
EPIZYME INC 0.7%
Value $18.86M Shares 1,779,094 Est. Cost Unrealized
OXFORD IMMUNOTEC GLOBAL PLC 0.6%
Value $17.65M Shares 1,087,359 Est. Cost Unrealized
DIPLOMAT PHARMACY INC 0.6%
Value $16.57M Shares 853,687 Est. Cost Unrealized
MORPHOSYS AG 0.6%
Value $16.02M Shares 600,000 Est. Cost Unrealized
ZBH ZIMMER BIOMET HLDGS INC 0.6%
Value $15.91M Shares 121,000 Est. Cost Unrealized
ARDX ARDELYX INC 0.5%
Value $15.19M Shares 3,491,922 Est. Cost Unrealized
SYROS PHARMACEUTICALS INC 0.5%
Value $15.11M Shares 1,268,945 Est. Cost Unrealized
AIMMUNE THERAPEUTICS INC 0.5%
Value $15.09M Shares 553,000 Est. Cost Unrealized
G1 THERAPEUTICS INC 0.5%
Value $15.01M Shares 287,000 Est. Cost Unrealized
CYMABAY THERAPEUTICS INC 0.5%
Value $14.88M Shares 1,343,181 Est. Cost Unrealized
KALV KALVISTA PHARMACEUTICALS INC 0.5%
Value $14.37M Shares 650,000 Est. Cost Unrealized
SIENTRA INC 0.5%
Value $14.18M Shares 593,769 Est. Cost Unrealized
AAC HLDGS INC 0.5%
Value $14.15M Shares 1,853,998 Est. Cost Unrealized
CTMX CYTOMX THERAPEUTICS INC 0.5%
Value $13.5M Shares 729,948 Est. Cost Unrealized
TNDM TANDEM DIABETES CARE INC 0.4%
Value $12.13M Shares 283,115 Est. Cost Unrealized
AVADEL PHARMACEUTICALS PLC 0.4%
Value $11.95M Shares 2,722,241 Est. Cost Unrealized
INVITAE CORP 0.4%
Value $11.51M Shares 688,062 Est. Cost Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 0.4%
Value $10.67M Shares 365,689 Est. Cost Unrealized
TELIGENT INC NEW 0.4%
Value $10.4M Shares 9,567,000 Est. Cost Unrealized
NIGHTSTAR THERAPEUTICS PLC 0.4%
Value $10.21M Shares 499,747 Est. Cost Unrealized
ALLAKOS INC 0.4%
Value $10.12M Shares 225,000 Est. Cost Unrealized
MELINTA THERAPEUTICS INC 0.3%
Value $9.132M Shares 2,311,858 Est. Cost Unrealized
BIOHAVEN PHARMACTL HLDG CO L 0.3%
Value $8.974M Shares 239,000 Est. Cost Unrealized
BLUEBIRD BIO INC 0.3%
Value $8.97M Shares 61,435 Est. Cost Unrealized
NUVASIVE INC 0.3%
Value $8.865M Shares 7,000,000 Est. Cost Unrealized
LIVN LIVANOVA PLC 0.3%
Value $8.864M Shares 71,500 Est. Cost Unrealized
QURE UNIQURE NV 0.3%
Value $8.786M Shares 241,430 Est. Cost Unrealized
KARYOPHARM THERAPEUTICS INC 0.3%
Value $8.089M Shares 475,000 Est. Cost Unrealized
VKTX VIKING THERAPEUTICS INC 0.3%
Value $8.013M Shares 460,000 Est. Cost Unrealized
INSP INSPIRE MED SYS INC 0.3%
Value $7.953M Shares 189,000 Est. Cost Unrealized
AUTL AUTOLUS THERAPEUTICS PLC 0.3%
Value $7.668M Shares 250,000 Est. Cost Unrealized
RA PHARMACEUTICALS INC 0.2%
Value $6.923M Shares 382,700 Est. Cost Unrealized
RCKT ROCKET PHARMACEUTICALS INC 0.2%
Value $6.894M Shares 280,000 Est. Cost Unrealized
NUVECTRA CORP 0.2%
Value $6.13M Shares 278,890 Est. Cost Unrealized
ALIMERA SCIENCES INC 0.2%
Value $5.932M Shares 6,052,935 Est. Cost Unrealized
PFENEX INC 0.2%
Value $5.465M Shares 1,069,514 Est. Cost Unrealized
GW PHARMACEUTICALS PLC 0.2%
Value $5.052M Shares 29,249 Est. Cost Unrealized
ADUS ADDUS HOMECARE CORP 0.2%
Value $4.601M Shares 65,590 Est. Cost Unrealized
CONSTELLATION PHARMCETICLS I 0.2%
Value $4.279M Shares 635,843 Est. Cost Unrealized
EIDOS THERAPEUTICS INC 0.2%
Value $4.196M Shares 420,409 Est. Cost Unrealized
ALBIREO PHARMA INC 0.1%
Value $3.955M Shares 120,000 Est. Cost Unrealized
ALPINE IMMUNE SCIENCES INC 0.1%
Value $3.879M Shares 612,867 Est. Cost Unrealized
IGI LABORATORIES INC 0.1%
Value $3.555M Shares 3,733,000 Est. Cost Unrealized
BIOSCRIP INC 0.1%
Value $3.172M Shares 1,023,379 Est. Cost Unrealized
TELIGENT INC NEW 0.1%
Value $2.8M Shares 708,873 Est. Cost Unrealized
SVRA SAVARA INC 0.1%
Value $2.79M Shares 250,000 Est. Cost Unrealized
PROTEON THERAPEUTICS INC 0.1%
Value $2.389M Shares 1,224,899 Est. Cost Unrealized
RA MED SYS INC 0.1%
Value $2.341M Shares 128,600 Est. Cost Unrealized
VYGR VOYAGER THERAPEUTICS INC 0.1%
Value $2.226M Shares 117,647 Est. Cost Unrealized
KIDS ORTHOPEDIATRICS CORP 0.1%
Value $2.134M Shares 58,247 Est. Cost Unrealized
FOAMIX PHARMACEUTICALS LTD 0.0%
Value $1.345M Shares 234,745 Est. Cost Unrealized
EYENOVIA INC 0.0%
Value $1.206M Shares 300,000 Est. Cost Unrealized
PERNIX THERAPEUTICS HLDGS IN 0.0%
Value $635K Shares 658,826 Est. Cost Unrealized
HISTOGENICS CORP 0.0%
Value $161K Shares 296,099 Est. Cost Unrealized